These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21782938)

  • 1. Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe.
    Bjerrum OJ
    Eur J Pharm Sci; 2011 Sep; 44(1-2):174-5. PubMed ID: 21782938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the teaching of pharmacology. (II. Practical classes, examinations)].
    Kharkevich DA
    Farmakol Toksikol; 1969; 32(2):244-50. PubMed ID: 5772153
    [No Abstract]   [Full Text] [Related]  

  • 3. Europe fiddles while innovation burns.
    Frantz S
    Nat Rev Drug Discov; 2005 Sep; 4(9):704-5. PubMed ID: 16178115
    [No Abstract]   [Full Text] [Related]  

  • 4. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ
    Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postgraduate training in veterinary pharmacology].
    Drumev D
    Vet Med Nauki; 1987; 24(9):95-100. PubMed ID: 3445459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apropos of the evolution of jobs and training in the pharmaceutical industry].
    Ardouin AC; Lavergne J; Pommaret C; Gayot A; Pourcelot Y; Traisnel M; Delage M; Lanet J; Villard E; Brun S
    Ann Pharm Fr; 1994; 52(2):110-2. PubMed ID: 7944179
    [No Abstract]   [Full Text] [Related]  

  • 8. A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Commentary.
    Amato A; Aringhieri E; Boccia S; Buccella F; Gorini B; Gramaglia D; Masetti R; Rossi P; Pelicci PG
    Ann Ist Super Sanita; 2017; 53(2):104-107. PubMed ID: 28617255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacist in the European Economic Community].
    Pharm Weekbl; 1970 Mar; 105(12):349-53. PubMed ID: 5417311
    [No Abstract]   [Full Text] [Related]  

  • 12. Has the European union achieved a single pharmaceutical market?
    Timur A; Picone G; DeSimone J
    Int J Health Care Finance Econ; 2011 Dec; 11(4):223-44. PubMed ID: 21984119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacy and pharmacology: friends or foes?
    Csáky TZ
    J Med Educ; 1973 Oct; 48(10):905-10. PubMed ID: 4728309
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
    Timur A; Picone G
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of future training needs for PhD graduates for European pharmaceutical companies: a report from the committee on industrial relations (CIR) of EUFEPS. European Federation for Pharmaceutical Sciences.
    Eur J Pharm Sci; 1999 Feb; 7(3):iii-v. PubMed ID: 10048939
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of undergraduate, nonprofessional pharmacology courses taught in colleges of pharmacy.
    Gerald MC
    Am J Pharm Educ; 1976 Aug; 40(3):239-45. PubMed ID: 1029404
    [No Abstract]   [Full Text] [Related]  

  • 17. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy making on data exclusivity in the European Union: from industrial interests to legal realities.
    Adamini S; Maarse H; Versluis E; Light DW
    J Health Polit Policy Law; 2009 Dec; 34(6):979-1010. PubMed ID: 20018988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulating pharmaceutical innovation in the EU.
    Annemans L; Cleemput I; Hulstaert F; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):235-9. PubMed ID: 21671690
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals gray markets turn off-white.
    Lowe LS; McCrohan KF
    J Hosp Mark; 1989; 3(2):121-31. PubMed ID: 10318329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.